AtriCure, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $174.7M | $155.1M | $129.8M | $107.5M | $81.9M | $70.2M | $64.4M | $59.0M |
| Cost of Revenue | $48.6M | $44.0M | $36.9M | $31.7M | $22.3M | $20.2M | $17.4M | $13.6M |
| Gross Profit | $126.2M | $111.1M | $92.9M | $75.8M | $59.6M | $50.0M | $47.0M | $45.4M |
| Gross Margin | 72.2% | 71.6% | 71.6% | 70.5% | 72.7% | 71.2% | 73.0% | 76.9% |
| Operating Expenses | ||||||||
| Research & Development | $34.1M | $35.8M | $25.7M | $18.6M | $13.4M | $12.1M | $11.9M | $11.5M |
| SG&A Expense | $117.0M | $106.4M | $93.9M | $73.5M | $57.0M | $45.1M | $39.9M | $37.0M |
| Operating Income | $-25.0M | $-31.1M | $-26.7M | $-16.4M | $-10.9M | $-7.2M | $-4.7M | $-3.2M |
| Operating Margin | -14.3% | -20.1% | -20.6% | -15.2% | -13.3% | -10.2% | -7.3% | -5.4% |
| Interest Expense | $2.3M | $1.8M | $292.0K | $305.0K | $566.0K | $802.0K | $814.0K | $862.0K |
| Pretax Income | $-26.9M | $-33.3M | $-27.2M | $-16.2M | $-11.4M | $-7.5M | $-5.4M | $-3.8M |
| Income Tax Expense | $14.0K | $40.0K | $36.0K | $33.0K | $18.0K | $50.0K | $31.0K | $19.0K |
| Net Income | $-26.9M | $-33.3M | $-27.2M | $-16.2M | $-11.5M | $-7.5M | $-5.5M | $-3.8M |
| Net Margin | -15.4% | -21.5% | -21.0% | -15.1% | -14.0% | -10.7% | -8.5% | -6.4% |
| EPS (Basic) | $-0.83 | $-1.05 | $-0.97 | $-0.61 | $-0.56 | $-0.47 | $-0.35 | $-0.25 |
| EPS (Diluted) | $-0.83 | $-1.05 | $-0.97 | $-0.61 | $-0.56 | $-0.47 | $-0.35 | $-0.25 |
| Shares Outstanding (Basic) | 34.6M | 33.3M | 32.3M | 27.6M | 23.2M | 16.9M | 16.4M | 15.7M |
| Shares Outstanding (Diluted) | 34.6M | 33.3M | 32.3M | 27.6M | 23.2M | 16.9M | 16.4M | 15.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |